Table 1.
The demographics and clinical characteristics of all the patients
| Characteristics | Groups | P | |
|---|---|---|---|
| Non-prolonged MV (n = 30) | Prolonged MV (n = 26) | ||
| Gender Males n (%) | 23 (76.67%) | 22 (84.62%) | 0.455 |
| Age (years) | 49.90 ± 16.60 | 54.27 ± 16.52 | 0.329 |
| SOFA | 11.09 ± 2.01 | 12.56 ± 2.71 | 0.003 |
| MV (hours) | 97.33 ± 26.97 | 280.50 ± 141.65 | < 0.001 |
| ICU LOS (days) | 8.13 ± 4.14 | 15.73 ± 7.02 | <0.001 |
| Types of surgery | |||
| CABG n (%) | 6 (20.00%) | 5 (19.23%) | 0.942 |
| Pericardiectomy n (%) | 10 (33.33%) | 13 (50.00%) | 0.206 |
| Valve surgery n (%) | 13 (43.33%) | 9 (34.62%) | 0.505 |
| Ventricular septal defect repair n (%) | 0 (00.00%) | 1 (3.85%) | 0.464 |
| Atrial neoplasms resection n (%) | 2 (6.67%) | 0 (0.00%) | 0.282 |
| Replacement of aorta n (%) | 1 (3.33%) | 0 (0.00%) | 1.000 |
| ECC duration (min) | 116.21 ± 98.56 | 82.56 ± 79.50 | 0.200 |
| Concomitant diseases | |||
| Hypertension n (%) | 11 (36.67%) | 6 (23.08%) | 0.270 |
| Diabetes n (%) | 7 (23.33%) | 3 (11.54%) | 0.310 |
| CAC n (%) | 8 (26.67%) | 5 (19.23%) | 0.511 |
| CKD n (%) | 4 (13.33%) | 1 (3.85%) | 0.358 |
| CHF n (%) | 8 (26.67%) | 9 (34.62%) | 0.519 |
| Post-surgery drugs | |||
| Vasopressors | |||
| 0-24 h n (%) | 28 (93.33%) | 26 (100%) | 0.494 |
| 24-48 h n (%) | 25 (83.33%) | 26 (100%) | 0.055 |
| > 48 h n (%) | 24 (80.00%) | 26 (100%) | < 0.001 |
| Intropes | |||
| 0-24 h n (%) | 28 (93.33%) | 25 (96.15%) | 1.000 |
| 24-48 h n (%) | 28 (93.33%) | 25 (96.15%) | 1.000 |
| > 48 h n (%) | 19 (63.33%) | 20 (76.92%) | 0.384 |
MV mechanical ventilation, SOFA sequential organ failure assessment, LOS length of stay, CABG coronary artery bypass grafting, ECC extracorporeal circulation, CAC coronary atherosclerotic cardiopathy, CKD chronic kidney disease, CHF chronic heart failure